Use of CMVs in livestock herds other than the herds of origin can be a time- and cost-saving strategy for veterinarians and producers. Until now, the nonadjacent-herd approval process was largely manual and paper-based. HerdPoint, which is exclusively available to Newport Laboratories customers, streamlines that process by bringing it online and removing the need to sign and send documentation through the mail.

HerdPoint also creates a portal through which veterinarians can view and manage all of their clients’ existing and past isolates from Newport Laboratories, giving them greater visibility into isolate status and expiration dates, including those from adjacent and nonadjacent herds. With all of this information in one place and accessible from a mobile device, veterinarians can provide real-time insights and recommendations to their clients on herd-health solutions.

“Based on working with livestock veterinarians on custom-made vaccines for the past 20 years, we understand how busy they are,” says Mike Steilen, head of marketing for Newport Laboratories. “HerdPoint gives them greater flexibility and allows them to spend less time behind their desks and more time in the field, working with their clients and ensuring the health and well-being of their animals.”

Specifically, HerdPoint allows veterinarians to easily accomplish the following tasks online:
• Fill out, sign, submit and track nonadjacent herd approval documents;
• View and manage isolates and custom-made vaccine records across their client portfolio, including product numbers, expiration dates, extension requests and more.

“We’re proud to show our dedication to the veterinarians we serve by creating a software that provides them with fast access to data,” says Edgar Diaz, DVM, MS, president of Newport Laboratories. “Customer service and innovation are at the core of who we are at Newport Laboratories, and HerdPoint is an example of how we bring those values to life.”

To learn more about Newport Laboratories and HerdPoint, including how you can get started using it, click here.

About Newport Laboratories

Newport Laboratories, Inc. is a Boehringer Ingelheim company and the nation’s leading manufacturer of custom-made vaccines. Located in Worthington, Minnesota, Newport Laboratories assists veterinarians and livestock producers in their efforts to address animal health problems through cutting-edge diagnostic testing and production of high-quality, evidence-based, custom-made vaccines. For further information, call 800-220-2522, email [email protected] or visit the Newport Laboratories website at http://www.newportlabs.com.

Boehringer Ingelheim

Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.

Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding 3 billion euros, corresponded to 17.0 percent of net sales.

As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success rather than short-term profit. The company therefore aims at organic growth from its own resources, with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility toward mankind and the environment.

More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.